Current through Register Vol. XLI, No. 50, December 13, 2024
Section 69-7-14 - Reports and Records14.1. Inspection Reports. 14.1.a. The secretary shall keep on file a report of any inspection, survey or investigation of an opioid treatment program or any program sponsor, owner, employee, volunteer or patient thereof.14.1.b. Information in reports or records shall be available to the public except for the following: 14.1.b.1. Information regarding complaints and subsequent investigations that is deemed confidential by any provision of this rule or applicable state or federal laws;14.1.b.2. Information of a personal nature from a patient or personnel file; or14.1.b.3. Information required to be kept confidential by state or federal law.14.1.c. A report of an inspection or investigation made public shall also state whether a plan of correction has been submitted to or approved by the secretary.14.2. Statistical Reports. 14.2.a. The opioid treatment program shall submit statistical reports to the secretary on reporting dates established by the secretary. The reporting dates shall be at least semi-annual.14.2.b. Within ninety days of the reporting dates established by the secretary the opioid treatment program shall file a statistical report with the secretary which includes the following information: 14.2.b.1. The total number of patients;14.2.b.2. The number of patients who have been continually receiving methadone treatment in excess of two years, including the total number of months of treatment for each of these patients;14.2.b.3. The state residency of each patient;14.2.b.4. The number of patients discharged from the program;14.2.b.5. The total months the patients were in the treatment program prior to discharge;14.2.b.6. Whether the discharge was for: 14.2.b.6.A. Termination or disqualification;14.2.b.6.B. Completion of a program of detoxification;14.2.b.6.C. Voluntary withdrawal prior to completion of all requirements of detoxification as determined by the opioid treatment program;14.2.b.6.D. Successful completion of the individualized treatment plan of care of care; or14.2.b.6.E. An unexplained reason;14.2.b.7. Statistics demonstrating program compliance with the random drug testing requirements of §16.2.a of this rule.14.2.b.8. Confirmation that the random drug tests were truly random in regard to both the patients tested and to the times random drug tests were administered by lottery or some other objective standard so as not to prejudice or protect any particular patient.14.2.b.9. Confirmation that the random drug tests were performed at least monthly for all program participants.14.2.b.10. The total number and the number of positive results;14.2.b.11. The number of expulsions from the opioid treatment program.